Skip to main content

Table 1 Study/Trial summary

From: Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk

Study or trial

Number of cancer types

Patients, n

CRC patients on L-OHP-based chemotherapy

Study A

9

2068

160

Study B

4

400

157

SENRI Trial

CRC only

413

344

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us